Safety and Immunogenicity of Cell-Based Quadrivalent Influenza Vaccine: A Randomized Trial | Citedby Results | Pediatrics | American Academy of Pediatrics

Skip to Main Content

Skip Nav Destination

Safety and Immunogenicity of Cell-Based Quadrivalent Influenza Vaccine: A Randomized Trial

Pediatrics (2022) 150 (5): e2022057509.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Lessons learnt from influenza vaccination in immunocompromised children undergoing treatment for cancer

Eliska Furlong
Rishi S Kotecha

The Lancet Child & Adolescent Health (2023)

Cell-Culture–Based Influenza Vaccines: Don’t Put All of Your Influenza Vaccines in the Egg Basket

Jennifer L. Nayak
Mary T. Caserta

Pediatrics (2022) 150 (5)